News Video | Policy | GPs | Hospitals | Medical | Mental Health | Welfare | Search


PHARMAC Working For Flexibility In Brand Changes

PHARMAC Still Working To Find Flexibility In Brand Changes

PHARMAC will keep working to find a practicable mechanism to provide some flexibility in its sole supply tender, says Manager Funding and Procurement Steffan Crausaz.

The Government drug-funder asked for feedback on a proposal to introduce a mechanism, called the Alternative Brand Allowance (ABA) to its tender for off-patent medicines. The mechanism would enable some people to remain on their existing medicine if there was a brand change and they found medical difficulties in changing brands.

Steffan Crausaz says responses to the consultation raised some concerns about the ABA that mean it can’t yet be put in place.

“The tender is an important way in which PHARMAC ‘frees up’ medicines funding, so it can be used to purchase other pharmaceuticals or healthcare. In this way, the tender is central to PHARMAC’s role of getting the best health outcomes from the pharmaceutical budget,” says Steffan Crausaz.

“We do recognise that some people have genuine medical difficulties in changing brands of their medicine, and we’d ideally like to have some more flexibility in the sole supply tendering process.”

“We asked for feedback on our proposal and have been told that the ABA as proposed won’t work effectively. This shows the benefits of asking the sector for its views in consultation. We need to take notice of these views and work through the valid concerns that were raised, which means we won’t be progressing the proposal at this time.

“We remain committed to seeking a way to give people some flexibility while maintaining the benefits that the tender provides.”

When it is considering changing medicines through the tender, PHARMAC already takes advice from an expert committee on clinical issues for people changing brands. Differences such as size or shape of tablets, colour, flavour, or whether a pill is coated or not, are all taken into account.

“The vast majority of people have no medical difficulty when the funded brand of a medicine changes. The solution we are seeking will respond to the needs of those people who might experience medical difficulty with changing brands as a result of the tender,” says Steffan Crausaz.

PHARMAC has run a tender for off-patent (older) medicines since 1997, and in this time it has generated savings of over $300 million. The 2008 tender, which is released this week, will be the first time PHARMAC runs an electronic tendering system. The electronic web-based system will make it easier to make and receive bids, and speed the process of assessing them.

This year the tender includes 724 products, and PHARMAC estimates savings of $20 million over three years to result from it.

Developing a mechanism for people who experience genuine medical difficulties changing brands was identified in the list of actions arising from Medicines New Zealand, which was released this month. Steffan Crausaz says PHARMAC will continue work to seek a solution in time for the 2008-09 tender. This work is a high priority for PHARMAC.

In the meantime, PHARMAC will continue to carefully consider what brand changes might mean for people taking each medicine.


© Scoop Media

Culture Headlines | Health Headlines | Education Headlines


Howard Davis: Emerald Fennell's Promising Young Woman'

The Guardian needed not one, but three reviews to do justice to Fennell's unsettling approach, which indicates exactly how ambiguous and controversial its message really is. More>>

Howard Davis: Jill Trevelyan's Rita Angus

Although Angus has become one of Aotearoa’s best-loved painters, the story of her life remained little known and poorly understood before Jill Trevelyan's acclaimed and revelatory biography, which won the Non Fiction Award at the Montana New Zealand Book Awards in 2009, and has now been republished by Te Papa press. More>>

Howard Davis: The Back of the Painting

Painting conservators are the forensic pathologists of the art world. While they cannot bring their subjects back to life, they do provide fascinating insights into the precise circumstances of a painting's creation, its material authenticity, and constructive methodology. More>>

Howard Davis: Black Panthers on the Prowl

A passionate and gripping political drama from Shaka King, this is an informative and instructive tale of human frailty that centers around the charismatic Chicago Black Panther leader Fred Hampton, who was murdered at the age of twenty-one during a police raid. More>>

Howard Davis: Controlling the High Ground

Stephen Johnson's raw and angry film not only poses important questions with scrupulous authenticity, but also provides a timely reminder of the genocidal consequences of casual bigotry and xenophobia. More>>

Howard Davis: Dryzabone - Robert Conolly's The Dry

After the terrible devastation caused by last year’s bushfires, which prompted hundreds of Australians to shelter in the ocean to escape incineration and destroyed uncountable amounts of wildlife, The Dry has been released during a totally different kind of dry spell. More>>

Howard Davis: Hit the Road, Jack - Chloé Zhao's Nomadland

Nomadland is perhaps the ultimately 'road' movie as it follows a group of dispossessed and disenfranchised vagabonds who find a form of communal refuge in camp sites and trailer parks after the economic contraction of 2008. More>>



  • Wellington
  • Christchurch
  • Auckland